The effect of chest wall hyperthermia on the blood oxygen saturation of Covid-19 patients

The effect of chest wall hyperthermia on the blood oxygen saturation of Covid-19 patients who suffered from lung disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201122049463N1

Enrollment

Registered

2021-01-18

Start date

2021-01-20

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19 Pneumonia. covid-19, virus identified

Interventions

Intervention 1: Intervention group: Covid-19 patients who suffered from Covid19 pneumonia, hospitalized and recieved National Pharmaceutical Protocol,will undergone hyperthermia via RF device,2 times

Eligibility

Sex/Gender

All

Age

17 Years to 75 Years

Inclusion criteria

Inclusion criteria: Positive nasopharyngeal or oropharyngeal PCR test No sign of underlying disease such as auto immunity disorders No sign of diabetes No sign of lung cancer SPO2 ( 85%-90%) , with out using external oxygen sources.

Exclusion criteria

Exclusion criteria: Patient's age > 75 SAO2 decrease 48 hours after local hyperthermia

Design outcomes

Primary

Measure	Time frame
Blood oxygen saturation. Timepoint: 1 hour before start the study, 1 hour after start the study, 1 times per 6 hours. Method of measurement: Oxygen saturaion system.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadbagher Tavakoli

Esfahan University of Medical Sciences

mb.tavakoli@mui.ac.ir+98 31 3792 9032

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026